Cassini Diletta, Cerullo Guido, Miccini Michelangelo, Manoochehri Farshad, Ercoli Alfredo, Baldazzi Gianandrea
1Policlinic of Abano Terme, Padova, Italy.
Surg Innov. 2014 Feb;21(1):52-8. doi: 10.1177/1553350613487804. Epub 2013 May 8.
Deep pelvic endometriosis is a complex disorder that affects 6% to 12% of all women in childbearing age. The incidence of bowel endometriosis ranges between 5.3% and 12%, with rectum and sigma being the most frequently involved tracts, accounting for about 80% of cases. It has been reported that segmental colorectal resection is the best surgical option in terms of recurrence rate and improvement of symptoms. The aim of this study is to analyze indications, feasibility, limits, and short-term results of robotic (Da Vinci Surgical System)-assisted laparoscopic rectal sigmoidectomy for the treatment of deep pelvic endometriosis.
Between January 2006 and December 2010, 19 women with bowel endometriosis underwent colorectal resection through the robotic-assisted laparoscopic approach. Intraoperative and postoperative data were collected. All procedures were performed in a single center and short-term complications were evaluated.
Nineteen robotic-assisted laparoscopic colorectal resections for infiltrating endometriosis were achieved. Additional procedures were performed in 7 patients (37%). No laparotomic conversion was performed. No intraoperative complications were observed. The mean operative time was 370 minutes (range = 250-720 minutes), and the estimated blood loss was 250 mL (range = 50-350 mL). The overall complication rate was 10% (2 rectovaginal fistulae).
Deep pelvic endometriosis is a benign condition but may have substantial impact on quality of life due to severe pelvic symptoms. We believe that robotic-assisted laparoscopic colorectal resection is a feasible and relatively safe procedure in the context of close collaboration between gynecologists and surgeons for treatment of deep pelvic endometriosis with intestinal involvement, with low rates of complications and significant improvement of intestinal symptoms.
深部盆腔子宫内膜异位症是一种复杂的疾病,影响6%至12%的育龄妇女。肠道子宫内膜异位症的发病率在5.3%至12%之间,直肠和乙状结肠是最常受累的部位,约占病例的80%。据报道,就复发率和症状改善而言,节段性结肠直肠切除术是最佳的手术选择。本研究的目的是分析机器人(达芬奇手术系统)辅助腹腔镜直肠乙状结肠切除术治疗深部盆腔子宫内膜异位症的适应证、可行性、局限性和短期结果。
2006年1月至2010年12月,19例肠道子宫内膜异位症患者通过机器人辅助腹腔镜方法接受结肠直肠切除术。收集术中及术后数据。所有手术均在单一中心进行,并评估短期并发症。
完成了19例机器人辅助腹腔镜结肠直肠切除术治疗浸润性子宫内膜异位症。7例患者(37%)进行了额外手术。未进行开腹手术转换。未观察到术中并发症。平均手术时间为370分钟(范围=250 - 720分钟),估计失血量为250 mL(范围=50 - 350 mL)。总体并发症发生率为10%(2例直肠阴道瘘)。
深部盆腔子宫内膜异位症是一种良性疾病,但由于严重的盆腔症状可能对生活质量产生重大影响。我们认为,在妇科医生和外科医生密切合作的情况下,机器人辅助腹腔镜结肠直肠切除术是治疗伴有肠道受累的深部盆腔子宫内膜异位症的一种可行且相对安全的手术,并发症发生率低,肠道症状有显著改善。